Zhengzhou

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.	Advanced Solid Tumors	Recruiting	Phase 1 / Phase 2	2026-08-06	NCT05944224
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 1 / Phase 2	2026-06-04	NCT06609005
A Study in Chinese Patients With Acquired Blepharoptosis	eye disorder, eyelid disorder, ptosis	Recruiting	Phase 3	2026-05-15	NCT06683651
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy	Primary Membranous Nephropathy	Recruiting	Phase 1	2026-04-30	NCT05668403

Clinical trials